Results 21 to 30 of about 36,449 (150)

Bioequivalence study of a new fixed-dose combination of valsartan and indapamide (modified-release tablets) versus concomitant administration of the respective reference single-ingredient products

Рациональная фармакотерапия в кардиологии
Aim. Тo evaluate the bioequivalence of Valsartan + Indapamide 160 mg + 1.5 mg modified release tablets developed by Gedeon Richter Polska Sp. z o. o. (Poland) compared to the reference products Diovan® (Siegfried Barbera S.L.
K. Tóth, M. A. García, B. D. Szmodics, A. Orosz, P. L. Herman, E. N. Balogh, B. I. Forgács, G. Magyar, E. Cseh, E. A. Pravkina   +9 more
doaj   +2 more sources

Menopausal metabolic syndrome after hysterectomy [PDF]

Кардиоваскулярная терапия и профилактика, 2005
Aim. To study indapamide retard 1,5 mg effects in women with menopausal metabolic syndrome (MMS) after hysterectomy. Material and methods. The study involved 25 women (mean age 43.82±4.08 years), who underwent subtotal hysterectomy, with one or two ...
V. I. Podzolkov, L. G. Mozharova, Yu. V. Khomitskaya   +2 more
doaj   +1 more source

Fixed drug eruption induced by indapamide. Cross-reactivity with sulfonamides [PDF]

, 1998
Indapamide is a nontiazidic sulfonamide diuretic which has not been previously reported as a cause of fixed drug eruption. We describe a patient who experienced several episodes of fixed drug eruption during treatment with indapamide.
Matheu, V., Matheu, Victor, Tornero, P., Sierra, Z, De Barrio, M., Sierra, Z., Zubeldia Ortuño, José Manuel, Tornero, P, Herrero, T., Herrero, T, De Barrio, M, Zubeldia, J M   +11 more
core   +2 more sources

The choice of combination antihypertensive therapy in patients with type 2 diabetes

Медицинский совет, 2015
The article tells about optimum choice of combination antihypertensive therapy in patients with diabetes mellitus 2. The article discusses the efficacy of combination therapy based on two types of RAAS blockade (angiotensin-converting enzyme inhibitor or
O. A. Koshelskaya, O. A. Zhuravleva, R. S. Karpov   +2 more
doaj   +1 more source

The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity

BioMed Research International, Volume 2018, Issue 1, 2018., 2018
Carbonic anhydrases constitute a group of enzymes that catalyse reversible hydration of carbon dioxide leading to the formation of bicarbonate and proton. The platelet carbonic anhydrase II (CAII) was described for the first time in the ′80s of the last century.
Maciej Jakubowski, Ewa Szahidewicz-Krupska, Adrian Doroszko, Agata Stanek   +3 more
wiley   +1 more source

INFLUENCE OF THE COMBINED ANTIHYPERTENSIVE THERAPY ON METABOLIC PROFILE AND CEREBRAL BLOOD FLOW IN PATIENTS WITH METABOLIC SYNDROME

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study influence of the combined antihypertensive therapy on blood pressure (BP), glucose and lipid metabolism as well as cerebral blood flow in patients with metabolic syndrome (МS)Material and methods. 60 patients with MS aged of 35-65 y.o. were
E. M. Idrisova, T. P. Kalashnikova, I. Yu. Efimova   +2 more
doaj   +3 more sources

Age‐Related White Matter Changes

Journal of Aging Research, Volume 2011, Issue 1, 2011., 2011
Age‐related white matter changes (WMC) are considered manifestation of arteriolosclerotic small vessel disease and are related to age and vascular risk factors. Most recent studies have shown that WMC are associated with a host of poor outcomes, including cognitive impairment, dementia, urinary incontinence, gait disturbances, depression, and increased
Yun Yun Xiong, Vincent Mok, Leonardo Pantoni   +2 more
wiley   +1 more source

Aggressive versus Low Dose Inhibition of the Renin‐Angiotensin System for the Treatment of Microalbuminuria in Type 2 Diabetic Patients: A Pilot Study

International Scholarly Research Notices, Volume 2011, Issue 1, 2011., 2011
Objective. This study compares low dose versus aggressive inhibition of the renin angiotensin system (RAS) to treat microalbuminuria (MA). Methods. Patients with MA after a run‐in period to control BP to <130/80 mm Hg with 10 mg benazepril plus other drugs and HbA1c levels to <8.0% were randomized to either continue 10 mg benazepril (N = 12) or to take
M. B. Davidson, N. Tareen, P. Duran, V. Aguilar, M. L. Lee, A. Hishinuma   +5 more
wiley   +1 more source

Update on the Treatment of Diabetic Retinopathy

The Scientific World Journal, Volume 8, Issue 1, Page 98-120, 2008., 2008
Retinopathy is the most feared complication of diabetes, compromising quality of life in most sufferers. Almost all patients with type 1 diabetes will develop retinopathy over a 15‐ to 20‐year period, and approximately 20–30% will advance to the blinding stage of the disease[1].
Jennifer L. Wilkinson-Berka, Antonia G. Miller, Mark Cooper   +2 more
wiley   +1 more source

Hyponatraemia and hypokalaemia due to indapamide [PDF]

, 2002
The document attached has been archived with permission from the editor of the Medical Journal of Australia (10 January 2008). An external link to the publisher’s copy is included.Objectives: To review Australian adverse drug reaction reports describing ...
Hanrahan, Ross, Marley, JE, Chapman, MD, Marley, John E., Hanrahan, R., Chapman, M., McEwen, J., Marley, J., McEwen, John, Chapman, Michael D., Hanrahan, R, McEwen, J   +11 more
core   +1 more source